|
No images? Click here The new way to treat depression, anxiety and chronic neuropathic pain Newsletter No 15 (6 October 2022)
KCSA Constantia relocates to our new clinic in Madison Place, Alphen ParkKCSA Constantia accepted its first patients at the new clinic on Friday 23rd September. Dr Mike Smit, Bea Hanslo and Sr Jenny Van Heerden look forward to accepting referrals from our psychiatrist colleagues in the region. The clinic is conveniently situated off the M41 (alongside the Norman Hershilwood High School), and is beautifully appointed. Patients can be collected after infusions directly from an elevator opening into undercover parking. Read KCSA's official statement on the relocation of its clinic.
FINALLY - quantification of ketamine and metabolites in human breast milk...
Ketamine infusion in breastfeeding mothers is safe and low exposure to the infant of ketamine or its metabolites in breastmilk will not lead to any significant clinical effects. Findings published in a recent article in the Journal of Psychoactive Drugs, provide evidence In a previous newsletter, we discussed the use of ketamine infusion for postpartum depression. Having now determined that infants are exposed to much lover levels of ketamine and its metabolites in breastmilk than anticipated, the door is open to this therapy without the need to cease breastfeeding. KetaMIND clinics currently offer outpatient ketamine infusions at the following locations:BEDFORDVIEW (GP) CAPE TOWN (WC) UMHLANGA (KZN) HILTON (KZN)
Overactivation and stimulation of the NMDA-receptor is likely the reason for Opioid Induced Hyperalgesia (OIH). This proposed mechanism would explain why NMDA-receptor modulators such as ketamine are effective in treating the condition. Learn more about OIH here.
Palliative and 'end-of-life' care ... what can ketamine offer? Ketamine infusion can offer benefits in this patient cohort for neuropathic pain, depression and opioid induced hyperalgaesia (OIH) A study published in the Annals of Palliative Medicine found that in a trial of 44-patients with uncontrolled pain despite opioids, outcome after ketamine infusion was considered 'optimal' or 'good' in 75% of participants. We previously linked to a paper demonstrating the efficacy of ketamine for Cancer-related Neuropathic Pain (CNP) of various etiologies in 57-patients.
|